Ankit Gupta

Ankit Gupta is a General Partner at Y Combinator, where he directs capital toward early-stage startup investments across multiple technology sectors. Prior to joining the venture accelerator, he co-founded Reverie Labs, a biotechnology enterprise utilizing machine learning infrastructure for computational drug discovery. During his tenure as a founder, the company advanced its proprietary medicines into clinical trials before executing an acquisition agreement with Ginkgo Bioworks in 2024. Before his entrepreneurial ventures, Gupta operated as a deep learning researcher, publishing technical papers at academic venues such as the International Conference on Machine Learning. He completed his higher education at Harvard University, earning both a Bachelor of Arts and a Master of Science in Computer Science. His current professional focus centers on venture capital allocation and founder mentorship within the artificial intelligence, machine learning, and biotechnology industries.